Literature DB >> 218934

Adenosine kinase from rabbit liver. II. Substrate and inhibitor specificity.

R L Miller, D L Adamczyk, W H Miller, G W Koszalka, J L Rideout, L M Beacham, E Y Chao, J J Haggerty, T A Krenitsky, G B Elion.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 218934

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  35 in total

1.  Molecular cloning and expression of adenosine kinase from Leishmania donovani: identification of unconventional P-loop motif.

Authors:  K M Sinha; M Ghosh; I Das; A K Datta
Journal:  Biochem J       Date:  1999-05-01       Impact factor: 3.857

2.  6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virus.

Authors:  D R Averett; G W Koszalka; J A Fyfe; G B Roberts; D J Purifoy; T A Krenitsky
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

3.  Antagonism of the cytotoxic but not antiviral effects of ara-sangivamycin by adenosine.

Authors:  G M Birch; S H Krawczyk; L B Townsend; J C Drach
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

4.  Methylation inhibitors can increase the rate of cytosine deamination by (cytosine-5)-DNA methyltransferase.

Authors:  J M Zingg; J C Shen; A S Yang; H Rapoport; P A Jones
Journal:  Nucleic Acids Res       Date:  1996-08-15       Impact factor: 16.971

Review 5.  Biochemistry and clinical applications of ribavirin.

Authors:  B E Gilbert; V Knight
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

6.  Nucleoside transporter subtype expression: effects on potency of adenosine kinase inhibitors.

Authors:  C J Sinclair; A E Powell; W Xiong; C G LaRivière; S A Baldwin; C E Cass; J D Young; F E Parkinson
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

7.  Adenosine kinase inhibition promotes survival of fetal adenosine deaminase-deficient thymocytes by blocking dATP accumulation.

Authors:  C Justin Van De Wiele; James G Vaughn; Michael R Blackburn; Catherine A Ledent; Marlene Jacobson; Hong Jiang; Linda F Thompson
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

8.  Nucleoside exchange catalysed by the cytoplasmic 5'-nucleotidase.

Authors:  Y Worku; A C Newby
Journal:  Biochem J       Date:  1982-09-01       Impact factor: 3.857

9.  Phosphorylated derivatives that activate or inhibit mammalian adenosine kinase provide insights into the role of pentavalent ions in AK catalysis.

Authors:  Jae Park; Bhag Singh; Mary C Maj; Radhey S Gupta
Journal:  Protein J       Date:  2004-02       Impact factor: 2.371

Review 10.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.